|Bid||0.00 x 0|
|Ask||639.15 x 0|
|Day's Range||633.90 - 648.60|
|52 Week Range||493.50 - 711.90|
|Beta (3Y Monthly)||0.98|
|PE Ratio (TTM)||20.35|
|Forward Dividend & Yield||2.00 (0.34%)|
|1y Target Est||663.61|
Feb 6 (Reuters) - Glenmark Pharmaceuticals Ltd: * SAYS ENTERS INTO AN EXCLUSIVE LICENSE AGREEMENT WITH GRANDPHARMA (CHINA) CO. LTD * SAYS AGREEMENT FOR COMMERCIALIZING INVESTIGATIONAL SEASONAL ALLERGIC ...
I am going to run you through how I calculated the intrinsic value of Glenmark Pharmaceuticals Limited (NSE:GLENMARK) by taking the foreast future cash flows of the company and discounting Read More...
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Glenmark Pharmaceuticals Limited (NSE:GLENMARK), with a market cap of ₹165.38b, are often out of theRead More...